BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Glucotrack Stock Surges 150% on Funding Deal and Investor Summit Participation
Glucotrack Stock Surges 150% on Funding Deal and Investor Summit Participation
12
3
BTCCSquare news:
Glucotrack (GCTK) shares skyrocketed 151.95% in pre-market trading after securing a $20 million equity purchase agreement with Sixth Borough Capital Fund. The medical device company gains flexible funding over 24 months through structured share sales, coupled with a Registration Rights Agreement.
Investor interest intensified as Glucotrack prepares to present at the Q3 VIRTUAL Investor Summit, with management slated for one-on-one meetings. The rally contrasts sharply with the stock's 98.91% YTD decline, suggesting speculative momentum rather than fundamental recovery.
By:
